The main category of All News Articles.
You can use the search box below to find what you need.
[wd_asp id=1]
The main category of All News Articles.
You can use the search box below to find what you need.
[wd_asp id=1]
Several popular dietary supplements have been recalled after they were linked to a nationwide salmonella outbreak.
Four products have been affected by a single lot of recalled organic moringa leaf powder — a nutritional supplement that can reduce inflammation — from Vallon Farmdirect of Jodhpur, India, according to a press release updated by the U.S. Food and Drug Administration Thursday. The powder was linked to multiple illnesses, including a multistate outbreak of salmonella infections, a common bacterial illness.
According to the FDA, two products from Food To Live, based in Brooklyn, New York, are being recalled because they used the lot of moringa leaf powder from Vallon Farmdirect. This includes Organic Moringa Leaf Powder, sold in eight-ounce, one-pound, two-pound, four-pound, eight-pound, 16-pound, and 44-pound bags.
The Organic Moringa Leaf Powder starts with lot codes of “SO-69006” through lot code “SO-72558.”
Food to Live is also recalling its Organic Supergreens Powder Mix, sold in eight-ounce, one-pound, one and a half-pound, three-pound, six-pound, and 12-pound bags. The product starts with lot codes of “SO-69006” through lot code “SO-72558.”
The two products were sold directly from Food To Live’s website and shipped nationwide. It was also sold on third-party e-commerce platforms, including Amazon.com, Walmart.com, Target, Etsy, and eBay.
In addition, Organic Moringa Leaf Powder, sold in a one-kilogram box on Africa Imports’ website after June 5, 2025, is being recalled. All of Member’s Mark Super Greens dietary supplement powder, regardless of lot codes and Best by dates on the product, have also been recalled.
According to the FDA, all four of these products were manufactured with “a single lot of organic moringa leaf powder,” supplied to the United States by Vallon Farmdirect. The powder, with lot code VFD/ORG/MORP/L/24code and the Best By Date of November 2027, “can explain all illnesses” included in the FDA’s investigation with the Centers for Disease Control and Prevention.
There have now been a total of 11 illnesses and three hospitalizations due to the salmonella outbreak. States with cases of salmonella infections include Florida, Kansas, Michigan, New York, North Carolina, South Carolina, and Virginia.
Out of 10 people who got sick and were interviewed by the CDC, nine of them reported eating powdered dietary supplements. Six of these people also reported eating Member’s Mark Super Greens Powder. In addition, three other people reported eating products with moringa leaf powder.
Salmonella infections can occur anywhere between 12 to 72 hours after eating food that is contaminated with salmonella, and symptoms can “usually last four to seven days,” per the FDA.
“Symptoms include diarrhea, fever, and abdominal cramps. Children younger than five, the elderly, and people with weakened immune systems are more likely to have severe infections,” according to the health organization.
Salmonella bacteria are the second leading cause of foodborne illnesses in the U.S., according to the CDC. The organization also notes that each year, there are 1.35 million illnesses, 420 deaths, and 26,500 hospitalizations due to salmonella.
There have been some major outbreaks of salmonella in the U.S. this year. In September, several home delivery meal kits from Metabolic Meals were linked to another multistate salmonella outbreak, which left seven people hospitalized.
The affected microwaveable meals, delivered the week of July 28 across different states, included: Four Cheese Tortellini with Pesto Sauce and Grilled Chicken, Low Carb Chicken Teriyaki and Vegetables, Black Garlic & Ranch Chicken Tenders with Roasted Vegetables, and Sliced Top Sirloin with Roasted Peanut Sauce and Summer Vegetables.
PRESS RELEASE
Published November 15, 2025
Cardano has been stuck below the $0.60 mark and traders are arguing whether it will rise in the short run. Although ADA has established a developed network with institutional coverage
Analysts forecast that it may move to $0.73-$0.87 in the short term, with December highs of about $0.90 and long-term goals in 2026. It can double or even triple the current levels, but an unrealistic increase would be needed to hit $5.
In the meantime, Remittix is quietly building some real buzz with some sharp-eyed investors on the hunt to find the next crypto rocket. It already has $28 million scooped and more than 40,000 verified backers who are not fooling around at just $0.1190 a token.
Analysts tracking ADA’s performance have pointed out that Cardano’s “next big move” may not be very big at all. Predictions for the short term put ADA somewhere between $0.73 and $0.87, with some December peaks estimated near $1.
These aren’t bad numbers, but they reflect the reality of a mature ecosystem that often moves at a slower pace.
As of mid-November 2025, ADA trades between $0.50 and $0.564 and sits in a narrow range & traders hoping for a major breakout.
Technical charts still offer a path toward higher prices, and a strong December could push ADA upward, but even optimistic forecasts push Cardano only toward $1.50-$2.00 through 2026. That’s a multi-year climb that depends heavily on adoption trends that aren’t guaranteed.

Remittix is a new L2 crypto protocol that aims to make cross-border payments easier. It is not based on the speculative projects, as it already has a working beta wallet that transfers crypto-to-bank transfers in 30+ countries, supports 40+ cryptocurrencies, and 30+ fiat currencies.
It has collected over $28 million and over 40,000 verified holders. This has guaranteed institutional backing and ensured its listings on key exchanges like BitMart and LBank.
Cardano’s path to meaningful appreciation relies on network effects, incremental adoption, and external catalysts such as ETF approvals. Growth is predictable. Remittix, by contrast, leverages adoption momentum and real-world usage, giving it an asymmetric risk-reward profile: Real talk, it could climb from $0.1190 straight up as more folks pile in and trading flows get deeper.
The $250,000 community giveaway highlights the growing urgency to participate. With over 370,000 entries, demand is rising while availability remains limited. Early participants also earn daily referral rewards, encouraging them to actively promote the platform and increasing adoption.
Cardano provides stability and measured returns for investors comfortable with slower growth. Remittix offers a rare opportunity for rapid expansion, driven by working infrastructure and a clear product-market fit in global payments.
For those deciding where to position themselves, the choice is simple: wait for ADA’s steady appreciation or participate in a project where adoption, utility, and referral-driven growth could create exponential returns.
Discover the future of PayFi with Remittix by checking out their project here:
Website: https://remittix.io/
Socials: https://linktr.ee/remittix
$250,000 Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway
Disclaimer:
This article is for informational purposes only and does not constitute financial advice. Cryptocurrency investments carry risk, including total loss of capital. Readers should conduct independent research and consult licensed advisors before making any financial decisions.
This publication is strictly informational and does not promote or solicit investment in any digital asset
All market analysis and token data are for informational purposes only and do not constitute financial advice. Readers should conduct independent research and consult licensed advisors before investing.
Crypto Press Release Distribution by BTCPressWire.com
COMTEX_470270694/2909/2025-11-15T05:37:05
XRP has been among the best-performing large-cap cryptocurrencies in the market.
Let’s dive into where this token could be headed from here, and why a $10 price target isn’t outlandish.
If you’re thinking about retiring or know someone who is, there are three quick questions causing many Americans to realize they can retire earlier than expected. take 5 minutes to learn more here
Ultra-low cost and high-efficiency blockchain project XRP (CRYPTO:XRP) has seen tremendous growth in recent years, as companies and individuals around the world look for the most efficient and cost effective ways to transfer value across borders.
For those who have not been involved in cross-border trade, or worked at a company with international operations, the concept of transferring large sums via the crypto sector may seem foreign. Indeed, the current SWIFT system and other global payment networks which connects banks works. But companies and individuals using such platforms will find themselves paying very high fees, often paying a wide spread on the currencies they’re exchanging, and each process can take days to clear.
On the other hand, those that use XRP’s XRP Ledger can see their money nearly instantaneously, with each transaction costing a fraction of a cent. That’s some pretty good value for those who are willing to jump through some initial hoops to set this up (I’d argue many similar hoops are involved in setting up large SWIFT transfers, for example, as well).
With that in mind, let’s dive into where some experts think XRP could be headed next year, and why I think $10 per token isn’t a completely unreasonable level.
As is the case with most major cryptocurrencies, analysts and experts covering this sector have cover to put forward what may seem like outlandish targets on where they think XRP (or any token for that matter) could be headed.
On the high end of the price target spectrum, I’ve seen price targets for XRP range from the $10 level to some in the $20-$30 range. Now, I’m not going to say such predictions are rock-solid, given the fact that most major cryptocurrencies such as XRP don’t have the same sort of fundamentals equities have (cash flows, earnings, revenue growth). That said, transaction volumes and overall network growth can be measured via various metrics, and there are plenty of encouraging signs that XRP and the Ripple team are moving in the right direction.
Among the key factors these crypto experts are pointing to as part of their rationale for why XRP could hit the $10 level or higher over the course of the next year comes down to four key elements.
Several dietary supplements containing the popular moringa leaf powder have been recalled after multiple consumers contracted Salmonella.
Products manufactured using a single lot of recalled organic moringa leaf powder from Vallon Farmdirect of Johdpur, India, have been linked to at least 11 illnesses and three hospitalizations included in a multi-state outbreak of Salmonella, according to the U.S. Food and Drug Administration (FDA).
Cases have been reported in Florida, Kansas, Michigan, New York, North Carolina, South Carolina and Virginia, and the affected products include Food to Live brand’s Organic Moringa Leaf Power (8-ounce, 1-pound, 2-pound, 4-pound, 8-pound, 16-pound, and 44-pound bags) and Organic Supergreens Power Mix (8-ounce, 1-pound, 1.5-pound, 3-pound, 6-pound, and 12-pound bags) with lot codes of SO-69006 through SO-72558.
Africa Import’s Organic Moringa Leaf Power (1-kilogram box) sold after June 5 is also affected, as are all Member’s Mark Super Greens dietary supplement powder products, regardless of lot codes and best by dates.
fda
The supplements were distributed nationwide through both retail and wholesale channels.
The FDA is now encouraging consumers and retailers to refrain from eating, selling or serving the recalled products and is instead urging that the products be thrown away, and that any surfaces or containers they may have touched be sanitized.
Never miss a story — sign up for PEOPLE’s free daily newsletter to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories.
fda
Salmonella is a group of bacteria that can cause gastrointestinal illness and fever called salmonellosis, according to the FDA.
Symptoms often begin to develop 12 to 72 hours after infection, and they may include diarrhea, fever, abdominal cramps, high fever, aches, headaches, lethargy, a rash and blood in the urine or stool. In some cases, it may become fatal.
After illnesses were reported in October, the Virginia Department of Health collected an open sample of Africa Imports moringa leaf powder from an affected individual’s home.
It later tested positive for Salmonella, based on a whole-genome sequencing that matched the strain causing illnesses in the outbreak.
fda
After more products, including an open sample of Member’s Mark Super Greens dietary supplement powder, yielded similar results, retailers ceased distribution and sales of the products and issued the voluntary recall.
According to the FDA, the investigation is ongoing and authorities are continuing to “determine what additional products were made with the implicated lot of moringa leaf powder.”
Moomoo SG just launched Solana trading. Thousands of retail traders who were stuck dealing with Binance verification and wallet hassles can now buy SOL the same way they buy Apple stock.
When platforms like Moomoo make crypto that easy, retail money floods in. And retail doesn’t just stack blue chips. They hunt the next breakout. They want SOL when it was $8, not $200.
But many aren’t chasing established L1s anymore. They’re positioning in presales before exchange listings, before the crowd shows up.
DeepSnitch AI is one of those rare setups. Already raised over $520K. Launched at $0.0151, the token has already jumped to $0.02289. That’s 50% gains, and it hasn’t touched a single exchange yet.
Five AI agents tracking whale moves, contract risks, and liquidity in real time. Actual utility that helps traders not get rekt. Here’s why the math for 100x is still on the table.
Solana trading just went live on Moomoo SG, and it’s important. Moomoo is a respected trading platform that bridges traditional finance and digital assets, particularly strong in the Asia-Pacific region. When a platform like this adds SOL to its roster, it’s not just about more liquidity. It’s about legitimacy and access.
Moomoo SG announced they’re now offering Solana trading directly to their user base. This means thousands of traders who were previously going through complex crypto exchanges can now buy SOL with the same ease they trade stocks.
For someone in Singapore who’s been curious about crypto but intimidated by Binance or Coinbase, Moomoo is familiar territory. They already have the app. They understand the interface. Now SOL is sitting right there next to their equity portfolio.
Accessibility drives adoption, and adoption drives price. When institutional-grade platforms start offering crypto assets, it signals confidence in those assets’ staying power.
DeepSnitch AI is an AI-powered blockchain analytics platform designed to give traders the information edge they need to make smarter decisions.
The platform uses advanced artificial intelligence to analyze blockchain transactions, identify suspicious patterns, and provide real-time intelligence on wallet behaviors.
It works as a professional analyst watching the blockchain 24/7, spotting rug pulls, pump schemes, and coordinated dumps to save you from the stampede.
Most meme projects have zero utility. They rely entirely on hype. The second that attention fades, so does the value. We’ve seen this pattern play out dozens of times in 2024 and 2025.
A coin pumps 500% in a week, everyone thinks they’re geniuses, then it crashes 80% and holders are left wondering what happened. DeepSnitch AI sidesteps this entire dynamic by offering something traders actually need: actionable intelligence.
DeepSnitch AI has a utility that addresses actual trader pain points. It’s launching during a period of expanding crypto adoption. And it’s still accessible at presale prices before the market discovers it. Early buyers are still at a 50% gain within months.
On Nov 13, Solana is trading in the $145 to $150 range after pulling back from recent highs. The SOL price has been consolidating, which means it’s building energy for the next move.

The Solana price prediction for 2026 ranges widely but skews bullish. Conservative estimates put SOL between $310 to $410 by late 2026, showing roughly 2x to 2.5x from current levels.
More optimistic forecasts see potential for SOL to reach $500 or even push toward its previous all-time high territory if market conditions align favorably.
Some traders point to pattern formations suggesting a measured move toward $450 based on historical Solana price action.
Continued ETF inflows matter enormously. If institutional buying pressure sustains or accelerates, it creates consistent demand that overwhelms selling pressure.
If crypto enters another bull phase in late 2025 or early 2026, which many indicators suggest is possible, Solana stands to benefit disproportionately.
Dash is trading around $66 on Nov 14 after getting absolutely wrecked from its November high. The coin ripped 50% in 24 hours in early November, hitting $149 and pushing its market cap to $1.8 billion, but that pump didn’t hold.
Dash peaked around $140 before dumping 40% as profit-taking crushed the rally and left traders holding bags.

The coin rallied over 550% from its summer low near $22, which made it one of the best performers in the privacy sector before the dump.
Bulls are targeting $150 to $200 if the privacy narrative holds, and some are calling for even higher if momentum returns.
Right now, Dash is consolidating in the $62-75 zone. The main risk is regulatory pressure and exchange delistings hitting privacy coins, which could keep a lid on any rally. The setup works if it holds above $58 support and catches the next wave of privacy coin rotation.
The picture forming around Solana price prediction heading into 2026 is compelling. Recent developments like the Moomoo SG listing are signals of a maturing market where accessibility and institutional participation are expanding rapidly.
Whether it lands at $300, $500, or somewhere in between depends on execution and market conditions.
Beyond SOL itself, the growing Solana ecosystem and the whole crypto-going-mainstream trend are creating room for early-stage projects that are actually building real utility. It’s opening the door for newer gems to shine, not just the big names.
DeepSnitch AI represents exactly the kind of opportunity that traders should be paying attention to right now.
If you want to make generational wealth this cycle, don’t sleep on the infrastructure being built. Don’t ignore the signs that institutional money is positioning.
And definitely don’t overlook projects that are launching now, in presale, with real utility and perfect timing.
Ready to explore what DeepSnitch AI can offer? Check out their presale and see why smart traders are allocating early before the market catches on.
Most analysts see Solana landing somewhere between $300 and $500 in 2026, with the super bullish calls pushing it closer to $800. It all comes down to how strong the next cycle is and how much new money flows into the big caps.
It’s not impossible, but it would take a crazy strong market and a huge wave of institutional money. The more realistic Solana price prediction for 2026 is still in the $400 to $500 zone based on today’s market cap and growth trends.
The Moomoo SG listing matters because it opens the door for regular retail investors who don’t usually use crypto exchanges. It puts Solana in front of a bigger, more traditional crowd that likes clean, regulated, easy-to-use platforms. More access usually means more demand.
Wia dis foto come from, EPA/Shutterstock
US President Donald Trump don sign one executive order wey go allow some food products, wey include coffee, bananas and beef escape im sweeping tariffs.
Di move dey come as im administration dey face mounting pressure ova rising cost of food.
While Trump bin previously downplay concerns about di cost of living, e don focus on di issue since im Republican Party poor performance for last week elections.
Di dozens of products wey dey di White House list of exemptions range from avocados and tomatoes to coconuts and mangoes.
Trump administration on Friday, 14 November tok say dem no fit produce these goods in sufficient quantities domestically.
Trump for long don tok say im tariffs – wey currently tanda for 10% baseline on imports from countries, plus additional levies on many trading partners – no go lead to increased prices for US consumers.
E bin also tok say affordability na “new word” and “con job” by Democrats.
E argue say taxes dey necessary to reduce US trade deficit – di gap between di value of goods dem dey buy from oda countries and dos wey dey sell to dem.
Trump bin tok say “cheaters” dey exploit US and foreigners dey tiff from dem. E bin add say higher levies go encourage pipo wey dey US to buy American goods instead.
But grocery costs plus di rising price of beef don bicom political issue for Trump.
E dey hope to rally support for di taxes, and e offer $2,000 tariff rebate cheques to Americans – even as di US Supreme Court currently dey check if Trump get di legal authority to implement dem.
On Friday, Trump tell tori pipo say di decision go affect products wey dem no dey produce for US, “so protection no dey for our industries, or our food products”.
E add say im no tink say more policy rollbacks go dey required in di future, e say “I no tink e go dey necessary.”
“We just do little bit of rollback on some foods, like coffee as example, as di prices of coffee bin dey a little bit high. Now dem go dey on di low side in a very short period of time,” Trump tok.
Economists bin warn say companies go pass di cost of di tariffs on dia customers in di form of higher prices.
While inflation bin dey okay pass wetin many analysts bin expect for September, most items wey di Department of Labor inflation bin track for dia report show say price increase, wit groceries up 2.7% from last year.
Di Trump administration new tariff exemptions for food products go take effect retroactively at midnight on Thursday 13 November, di White House tok.
Di White House bin release one list wey include more dan 100 products wey no longer dey subject to di levies. Some of dem include:
The recent Cardano price prediction paints a slow recovery story. ADA has dropped by 9.3 percent in the last 24 hours and , way below its previous levels. believe that Cardano is unlikely to see $3 again until 2028, unless a big trend change happens. An increase in the trading volume and a loss in price imply increased selling pressure and not reassured confidence.
The market indicators demonstrate that liquidity keeps leaving Cardano, and 50-day, 100-day, and 200-day moving averages are all against ADA. Sellers continue to be in control by rejecting every recovery push since its breakdown in October. The RSI of almost 34 indicates that ADA might decrease further before reaching an oversold point.
Long-term holders are feeling the strain. Cardano’s whales have offloaded millions of tokens, and futures data shows consistent outflows, with ADA recently. Unless sentiment shifts, the Cardano price prediction points toward prolonged stagnation. Many traders are already accepting that ADA may need several market cycles before returning to the $3 level last seen in the 2021 bull run.
The crypto market traded mixed over the past 24 hours, with Real World Assets (RWA) and NFT sectors leading gains while Bitcoin (BTC) slipped below the $103,000 mark. The RWA sector rose 2.05%, driven by Sky (SKY) up 9.01% and Keeta (KTA) up 5.32%. NFT tokens also climbed 2.01%, led by Zora (ZORA) soaring nearly 19.5%. Meanwhile, BTC fell 0.8% and Ethereum (ETH) edged up 0.56% to hover around $3,400. PayFi tokens gained 1.51%, boosted by Telcoin (TEL) surging 61.7%, while the Meme and Layer 1 sectors posted minor losses despite standout performers like Zcash (ZEC) and Giggle Fund (GIGGLE).
But what else is happening in crypto news today? Follow our up-to-date live coverage below.
The post [LIVE] Crypto News Today: Latest Updates for Nov. 13, 2025 – RWA and NFT Tokens Lead Market Gains as Bitcoin Slips Below $103K appeared first on Cryptonews.
Vitamins and dietary supplements are often viewed as harmless additions to daily health routines, but recent scientific evidence shows that certain high-dose supplements may cause more harm than good. While vitamins are essential for normal body function, excessive or unnecessary supplementation can place significant stress on the heart, liver and metabolic system. Fat-soluble vitamins, in particular, tend to accumulate in the body, increasing the risk of toxicity when taken in large amounts.
1. Vitamin AVitamin A is essential for vision, immunity and skin health. However, because it is fat-soluble, the body stores excess amounts in the liver rather than excreting them. High-dose supplementation can therefore lead to accumulation and toxicity, causing liver inflammation, fibrosis and, in severe cases, liver failure. Excessive Vitamin A intake has also been associated with increased pressure inside the skull, bone fragility and potential disturbances in cholesterol metabolism, indirectly affecting cardiovascular health when consumed at unsafe levels.
A study published in the Journal of Hepatology reported that chronic high intake of Vitamin A significantly increased the risk of liver toxicity, with biopsy samples showing liver cell injury, fibrosis and early signs of cirrhosis among long-term high-dose users.2. Vitamin DVitamin D supports bone strength, immune function and hormone regulation. However, excessive supplementation can lead to Vitamin D toxicity, a condition that causes dangerously high calcium levels in the blood (hypercalcaemia). This can harden and calcify blood vessels, damage heart valves, and strain the kidneys and liver. High-dose Vitamin D is often taken without testing levels first, which increases the risk of accidental overdose and long-term cardiovascular complications.A study in the American Journal of Medicine found that individuals taking high-dose Vitamin D supplements had an increased risk of hypercalcaemia, which was associated with vascular calcification and reduced cardiovascular function.3. Vitamin EVitamin E is a powerful antioxidant, but when taken in large supplemental doses, it can thin the blood excessively and interfere with normal clotting. This may raise the risk of haemorrhagic stroke and increase bleeding tendencies. Some research also suggests that high doses may contribute to oxidative stress in the liver and disrupt lipid metabolism, creating additional cardiovascular strain.A study published in the Journal of the American Medical Association (JAMA) concluded that high-dose Vitamin E supplementation was linked to an increased risk of haemorrhagic stroke. The findings indicated that doses above 400 IU daily may raise the likelihood of uncontrolled bleeding.4. Niacin (Vitamin B3)Niacin is used to support cholesterol management and energy production. However, supplement forms often contain doses far exceeding dietary needs. High-dose niacin can overload the liver, causing enzyme elevation, hepatitis or liver failure. It also increases inflammation in blood vessels and may promote arterial plaque buildup, reversing the very heart-protective effects it is often taken for.A study in Nature Medicine found that elevated niacin metabolites were strongly associated with arterial inflammation and a higher risk of cardiovascular events. The study suggested that excessive niacin intake may contribute to plaque formation and worsen heart disease risk.5. Green tea extractGreen tea extract contains concentrated levels of catechins, especially EGCG. While drinking green tea is safe, the supplement form delivers much higher doses, which can overwhelm the liver’s detoxification pathways. Liver injury caused by high-dose green tea extract has been reported worldwide, especially in weight-loss supplements. Excess catechins may also raise oxidative stress and strain cardiovascular function.A study published in the European Food Safety Authority (EFSA) Journal concluded that catechin intake above 800 mg per day could cause liver enzyme elevation and increase the risk of liver injury. The review highlighted high-dose green tea extract as a major contributor to supplement-induced liver toxicity.Disclaimer: This article is for informational purposes only and should not be considered medical advice. Please consult a healthcare professional before making any changes to your diet, medication, or lifestyle.